Charles Stanley, MD, the founding director of the Congenital Hyperinsulinism Center at CHOP, was presented with a lifetime achievement award by Congenital Hyperinsulinism International (CHI) at the Sugar Soiree in New York City in November.
CHI Executive Director Julie Raskin recognized Dr. Stanley for his extraordinary dedication to patients and the study of hyperinsulinism.
“HI babies and children need an army of people with a deep curiosity and hunger to understand the condition and search for better treatments, and a love of sharing this knowledge with others,” Raskin said, calling Dr. Stanley “a pediatrician who has it all: brains, empathy, curiosity, a sense of humor, dedication and kindness.”
She went on to highlight some of Dr. Stanley’s contributions:
- In 1976, while still a pediatric endocrine fellow, Dr. Stanley co-authored a paper on the diagnosis and treatment of HI in babies that began to raise awareness of HI.
- In the 1990s, Dr. Stanley was able to demonstrate that HI is a genetic condition, work that has led to the discovery of 10 genes now known to be associated with HI.
- In 1998, he founded CHOP’s HI Center and has spearheaded advances in diagnosis and treatment, including the use of the 18F-DOPA PET scan to identify focal HI lesions, leading to a cure for 95 percent of patients with focal HI.
“All of us here tonight are so grateful to you for your commitment to us and to this work,” Raskin said.